{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,16]],"date-time":"2026-11-16T22:07:26Z","timestamp":1794866846616,"version":"4.9.1"},"reference-count":23,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2012,10,1]],"date-time":"2012-10-01T00:00:00Z","timestamp":1349049600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["International Journal of Pharmaceutics"],"published-print":{"date-parts":[[2012,10]]},"DOI":"10.1016\/j.ijpharm.2012.07.010","type":"journal-article","created":{"date-parts":[[2012,7,18]],"date-time":"2012-07-18T15:10:33Z","timestamp":1342624233000},"page":"472-477","source":"Crossref","is-referenced-by-count":35,"title":["Single-pass intestinal perfusion to establish the intestinal permeability of model drugs in mouse"],"prefix":"10.1016","volume":"436","author":[{"given":"Elvira","family":"Escribano","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xavier Garc\u00eda","family":"Sala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorge","family":"Salamanca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia Roig","family":"Navarro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josep Queralt","family":"Regu\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijpharm.2012.07.010_bib0005","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1023\/A:1025088628787","article-title":"Quantitative evaluation of the function of small intestinal p-glycoprotein: comparative studies between in situ and in vitro","volume":"20","author":"Adachi","year":"2003","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ijpharm.2012.07.010_bib0010","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1023\/A:1016212804288","article-title":"A theoretical basis for a biopharmaceutic drug classification: the correlation of in vitro drug product dissolution and in vivo bioavailability","volume":"12","author":"Amidon","year":"1995","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ijpharm.2012.07.010_bib0015","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1007\/s11095-006-9041-2","article-title":"Why is it challenging to predict intestinal drug absorption and oral bioavailability in human using rat model","volume":"23","author":"Cao","year":"2006","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ijpharm.2012.07.010_bib0020","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1208\/s12248-009-9144-x","article-title":"Prediction of solubility and permeability class membership: provisional BCS classification of the world's top oral drugs","volume":"11","author":"Dahan","year":"2009","journal-title":"AAPS J."},{"key":"10.1016\/j.ijpharm.2012.07.010_bib0025","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1023\/A:1016065715308","article-title":"Comparison between permeability coefficients in rat and human jejunum","volume":"13","author":"Fagerholm","year":"1996","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ijpharm.2012.07.010_bib0030","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/0306-4522(87)90369-1","article-title":"The number of neurons in the small intestine of mice, guinea pigs and sheep","volume":"22","author":"Gabella","year":"1987","journal-title":"Neuroscience"},{"key":"10.1016\/j.ijpharm.2012.07.010_bib0035","series-title":"Drug Absorption Studies: In Situ, In Vitro and In Silico Models. Volume VII (Biotechnology: Pharmaceutical Aspects)","first-page":"34","article-title":"Models of the small intestine","author":"Griffin","year":"2008"},{"key":"10.1016\/j.ijpharm.2012.07.010_bib0040","unstructured":"Guidance for industry. Waiver of in vivo bioavailability and bioequivalence studies for immediate-release solid oral dosage forms based on a biopharmaceutics classification system. August 2000 (http:\/\/www.fda.gov\/cder\/guidance\/index.htm (accesed February 2012))."},{"key":"10.1016\/j.ijpharm.2012.07.010_bib0045","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1124\/dmd.110.032771","article-title":"In situ intestinal perfusion in knockout mice demonstrates inhibition of intestinal p-glycoprotein by Ritonavir causing increased Darunavir absorption","volume":"38","author":"Holmstock","year":"2010","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.ijpharm.2012.07.010_bib0050","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1021\/mp0498852","article-title":"Disposition of formononetin via enteric recycling: metabolism and excretion in mouse intestinal perfusion and Caco-2 cell models","volume":"2","author":"Jeong","year":"2005","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ijpharm.2012.07.010_bib0055","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1021\/mp060042f","article-title":"The suitability of an in situ perfusion model for permeability determinations: utility for BCS Class I biowaiver requests","volume":"3","author":"Kim","year":"2006","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ijpharm.2012.07.010_bib0060","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1023\/A:1015888813741","article-title":"Regional jejunal perfusion, a new in vivo approach to study oral drug absorption in man","volume":"9","author":"Lennern\u00e4s","year":"1992","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ijpharm.2012.07.010_bib0065","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1021\/js970332a","article-title":"Human intestinal permeability","volume":"87","author":"Lennern\u00e4s","year":"1998","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ijpharm.2012.07.010_bib0070","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/S0928-0987(02)00005-2","article-title":"The effect of amiloride on the in vivo effective permeability of amoxicillin in human jejunum: experience from a regional perfusion technique","volume":"15","author":"Lennern\u00e4s","year":"2002","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ijpharm.2012.07.010_bib0075","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1177\/1087057104267162","article-title":"Comparison of in vitro models for the prediction of compound absorption across the human intestinal mucosa","volume":"9","author":"Miret","year":"2004","journal-title":"J. Biomol. Screen."},{"key":"10.1016\/j.ijpharm.2012.07.010_bib0080","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1124\/dmd.109.026591","article-title":"Intestinal perfusion with mesenteric blood sampling in wild-type and knockout mice. Evaluation of a novel tool in biopharmaceutical drug profiling","volume":"37","author":"Mols","year":"2009","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.ijpharm.2012.07.010_bib0085","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1177\/108705710100600309","article-title":"High throughput prediction of oral absorption: improvement of the composition of the lipid solution used in parallel artificial membrane permeation assay","volume":"6","author":"Sugano","year":"2001","journal-title":"J. Biomol. Screen."},{"key":"10.1016\/j.ijpharm.2012.07.010_bib0090","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1023\/A:1020483911355","article-title":"Comparison of human duodenum and Caco-2 gene expression profiles for 12000 gene sequences tags and correlation with permeability of 26 drugs","volume":"10","author":"Sun","year":"2002","journal-title":"Pharm. Res."},{"issue":"3","key":"10.1016\/j.ijpharm.2012.07.010_bib0120","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1208\/ps030325","article-title":"Comparison of the gravimetric, phenol red, and 14C-PEG-3350 methods to determine water absorption in the rat single-pass intestinal perfusion model","volume":"3","author":"Sutton","year":"2001","journal-title":"AAPS Pharm. Sci."},{"key":"10.1016\/j.ijpharm.2012.07.010_bib0100","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1023\/A:1012134219095","article-title":"Human intestinal permeability of Piroxicam, Propanolol, Phenylalanine, and PEG400 determined by jejunal perfusion","volume":"14","author":"Takamatsu","year":"1997","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ijpharm.2012.07.010_bib0105","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1023\/A:1011020025338","article-title":"Human jejunal permeability of two polar drugs: cimetidine and ranitidine","volume":"18","author":"Takamatsu","year":"2001","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ijpharm.2012.07.010_bib0110","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.1002\/jps.20309","article-title":"Prediction of in vivo intestinal absorption enhancement on p-glycoprotein inhibition, from rat in situ permeability","volume":"94","author":"Varma","year":"2005","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ijpharm.2012.07.010_bib0115","first-page":"368","article-title":"Predicting human intestinal permeability using single-pass intestinal perfusion in rat","volume":"10","author":"Zakeri-Milani","year":"2007","journal-title":"J. Pharm. Sci."}],"container-title":["International Journal of Pharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378517312006850?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378517312006850?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,11,22]],"date-time":"2018-11-22T03:30:59Z","timestamp":1542857459000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0378517312006850"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,10]]},"references-count":23,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2012,10]]}},"alternative-id":["S0378517312006850"],"URL":"https:\/\/doi.org\/10.1016\/j.ijpharm.2012.07.010","relation":{},"ISSN":["0378-5173"],"issn-type":[{"value":"0378-5173","type":"print"}],"subject":[],"published":{"date-parts":[[2012,10]]}}}